€57.00
0.00% yesterday
Xetra, Jun 30, 05:35 pm CET
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Carl Zeiss Meditec Stock price

€57.00
+0.10 0.18% 1M
+11.48 25.22% 6M
+11.48 25.22% YTD
-9.25 13.96% 1Y
-56.90 49.96% 3Y
-29.80 34.33% 5Y
+34.13 149.23% 10Y
+46.04 419.99% 20Y
Xetra, Closing price Mon, Jun 30 2025
+0.00 0.00%
ISIN
DE0005313704
Symbol
AFX
Index
Sector

Key metrics

Basic
Market capitalization
€5.1b
Enterprise Value
€5.6b
Net debt
€543.4m
Cash
€51.5m
Shares outstanding
87.5m
Valuation (TTM | estimate)
P/E
32.02 | 29.89
P/S
2.35 | 2.30
EV/Sales
2.60 | 2.55
EV/FCF
68.01
P/B
2.40
Dividends
DPS
€0.60
Yield 1Y | 5Y
1.05% | 0.72%
Growth 1Y | 5Y
-45.45% | -1.59%
Payout 1Y | 3Y
29.85% | 32.75%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€2.2b | €2.2b
EBITDA
€339.1m | €395.5m
EBIT
€185.4m
Net Income
€155.9m | €167.0m
Free Cash Flow
€83.0m
Growth (TTM | estimate)
Revenue
5.21% | 7.16%
EBITDA
8.05% | 20.86%
EBIT
-40.66%
Net Income
-40.32% | -6.58%
Free Cash Flow
638.99%
Margin (TTM | estimate)
Gross
52.43%
EBITDA
15.63% | 17.86%
EBIT
8.55%
Net
7.19% | 7.54%
Free Cash Flow
3.82%
Financial Health
Equity Ratio
60.17%
Return on Equity
8.75%
ROCE
6.52%
ROIC
4.81%
Debt/Equity
0.29
More
EPS
€1.78
FCF per Share
€0.95
Short interest
-
Employees
5.73k
Rev per Employee
€360.00k
Show more

Is Carl Zeiss Meditec a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.

Carl Zeiss Meditec Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Carl Zeiss Meditec forecast:

9x Buy
41%
12x Hold
55%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Carl Zeiss Meditec forecast:

Buy
41%
Hold
55%
Sell
5%

Financial data from Carl Zeiss Meditec

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
2,169 2,169
5% 5%
100%
- Direct Costs 1,032 1,032
15% 15%
48%
1,137 1,137
2% 2%
52%
- Selling and Administrative Expenses 631 631
25% 25%
29%
- Research and Development Expense 322 322
10% 10%
15%
339 339
8% 8%
16%
- Depreciation and Amortization 154 154
11,451% 11,451%
7%
EBIT (Operating Income) EBIT 185 185
41% 41%
9%
Net Profit 156 156
40% 40%
7%

In millions EUR.

Don't miss a Thing! We will send you all news about Carl Zeiss Meditec directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Carl Zeiss Meditec Stock News

AD HOC NEWS
4 days ago
Die Schweizer Großbank UBS hat Carl Zeiss Meditec DE0005313704 auf "Neutral" belassen.
AD HOC NEWS
about 2 months ago
Der Jenaer Medizintechnik-Konzern Carl Zeiss Meditec DE0005313704 sieht sich trotz eines Ergebnisrückgangs im ersten Halbjahr auf Kurs zu seinen Jahreszielen.
AD HOC NEWS
about 2 months ago
Carl Zeiss Meditec AG / DE0005313704
More Carl Zeiss Meditec News

Company Profile

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Devices and Microsurgery business segments. The Ophthalmic Devices segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded on October 4, 1995 and is headquartered in Jena, Germany.

Head office Germany
CEO Markus Weber
Employees 5,730
Founded 1995
Website www.zeiss.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today